Tanner Pharma Group is proud to serve as the title sponsor for The Max Foundation’s 2018 “Max Global Experience: Uganda,” an expedition to raise awareness and funds for increased cancer treatment access in Africa.
In August, Banks Bourne, Founder & Chairman of Tanner Pharma Group / CEO of Bourne Partners, and Rob Keel, Director of TannerMAP, made the journey to Uganda to help bridge the “last mile” of treatment access for cancer patients. The “last mile” refers to the unseen efforts of patients and caregivers to make treatment truly accessible. The fundraising and trip were meant to echo the journey cancer survivors take (sometimes walking many miles) to get the treatment, care, and support they need. While in Uganda, the team attended the #MaxLastMile Symposium in Entebbe and met with patients, partners, and doctors to discuss local needs, advocacy techniques, and the future of treatment access.
In support of The Max Foundation’s efforts, the Bourne Partners and Tanner Pharma teams joined forces globally to walk a combined 7,500 miles (the distance between Charlotte, NC & Uganda) during the 8 weeks leading up to the event. Participants tracked the distance they walked, ran, and cycled. All together the Bourne & Tanner Pharma teams walked 7,667 miles.
About Tanner Pharma Group
For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.
Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.
Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.